Ricardo Paraense

Dr. Ricardo Paraense

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Maria Elena Crespo-LópezMaria Elena Crespo-López
Maria Elena Crespo-López
ESEricks Soares
Ericks Soares
BMBarbarella Macchi
Barbarella Macchi
LSLeticia Santos-Sacramento
Leticia Santos-Sacramento
PTPriscila Yuki Takeda
Priscila Yuki Takeda
GAGabriela Arrifano
Gabriela Arrifano
Methylmercury (MeHg) exposure is a serious problem of public health, especially in the Amazon. Exposure in riverine populations is responsible for neurobehavioral abnormalities. It was hypothesized that consumption of Amazonian fruits could protect by reducing mercury accumulation. This work analyzed the effects of commercial samples of Euterpe oleracea (EO) for human consumption (10 μL/g) against MeHg i.p. exposure (2.5 mg/Kg), using neurobehavioral (open field, rotarod and pole tests), biochemical (lipid peroxidation and nitrite levels), aging-related (telomerase reverse transcriptase (TERT) mRNA expression) and toxicokinetic (MeHg content) parameters in mice. Both the pole and rotarod tests were the most sensitive tests accompanied by increased lipid peroxidation and nitrite levels in brains. MeHg reduced TERT mRNA about 50% demonstrating a strong pro-aging effect. The EO intake, similar to that of human populations, prevented all alterations, without changing the mercury content, but avoiding neurotoxicity and premature aging of the Central Nervous System (CNS). Contrary to the hypothesis found in the literature on the possible chelating properties of Amazonian fruits consumption, the effect of EO would be essentially pharmacodynamics, and possible mechanisms are discussed. Our data already support the regular consumption of EO as an excellent option for exposed Amazonian populations to have additional protection against MeHg intoxication.

GAGabriela Arrifano
Gabriela Arrifano
Jacqueline Isaura Alvarez-LeiteJacqueline Isaura Alvarez-Leite
Jacqueline Isaura Alvarez-Leite
JSJosé Rogério Souza-Monteiro
José Rogério Souza-Monteiro
Marcus OliveiraMarcus Oliveira
Marcus Oliveira
RPRicardo Paraense
Ricardo Paraense
Maria Elena Crespo-LópezMaria Elena Crespo-López
Maria Elena Crespo-López
The Amazon River basin is the largest tropical forest in the world. Most of the Amazon belongs to Brazil, a developing country that currently faces huge challenges related to the consolidation of its universal healthcare system. Noncommunicable diseases (NCDs) are the leading cause of death in Brazil, accounting for 74% of all deaths, and NCDs are probably underestimated in Amazonian population because of their geographical isolation and the precariousness of riverine communities. Important risk factors, such as genetic susceptibility, remain undetermined in the riverine population. This study performed fasting blood sugar (FBS) and blood pressure measurements and investigated the presence of the ε4 allele of apolipoprotein E (APOE4) to determine the prevalence of diabetes, hypertension and the genetic risk of NCDs. FBS and APOE4 were measured in blood samples from 763 participants using spectrometry and real-time PCR; 67.5% showed altered measurements, and 57.9% had never been diagnosed or treated. Altered FBS was found in 28.3% of the participants, hypertension in 57.6% and APOE4 in 32.0%. The health profile of the riverine population appears to differ from that of urban population in the Amazon. Additional risk factors for NCDs, such as environmental contamination and nutritional transition, may contribute more than increased genetic susceptibility to the prevalence of altered FBS and hypertension. Our results will help guide the development of preventive strategies and governmental actions for more effective management of NCDs in the Amazon area.

1 January 2017 in Metallomics
Verified
Journal Article
Open access
PDF file
PFPaulo Mecenas Alves Farias-Junior
Paulo Mecenas Alves Farias-Junior
FTFrancisco Bruno Teixeira
Francisco Bruno Teixeira
NFNathalia Fernandes Fagundes
Nathalia Fernandes Fagundes
GMGiza Hellen Nonato Miranda
Giza Hellen Nonato Miranda
LBLeonardo Oliveira Bittencourt
Leonardo Oliveira Bittencourt
Rafael Rodrigues LimaRafael Rodrigues Lima
Rafael Rodrigues Lima
Methylmercury (MeHg) is one of the most toxic species of mercury, causing several systemic damages; however, its effect on the salivary glands has rarely been explored to date.

1 May 2017 in Preprints.org
Verified
Preprint
Open access
MSMaria Elisabete Silva Santos
Maria Elisabete Silva Santos
RPRicardo Paraense
Ricardo Paraense
ECEric Artur Cortinhas-Alves
Eric Artur Cortinhas-Alves
DPDanilo Leôncio Aguiar Pereira
Danilo Leôncio Aguiar Pereira
The atherosclerosis, a chronic and inflammatory disease that occurs when there are high levels of low-density lipoprotein (LDL) on plasma. This important risk factor for development of cardiovascular disease (CVD) is the main cause of death worldwide. MicroRNAs have recently emerged as potential biomarkers and therapeutic target for lipid metabolism disorders. In this review, we will provide profile of surrounding miRNAs that have demonstrated being regulators of PCSK9, LDLR and APOB100 genes. Recent work has identified the mir-148, mir-128, mir-27a/b, mir-185, mir-301, mir-130 as important regulators of this pathway because they decrease supply of LDL receptors through interaction with PCSK9. Inhibition of LDLR expression cause elevation of plasma LDL levels which induces atherosclerosis. While mir-30c, mir-122, mir-34 decrease MTTP, which promotes degradation of APOB100 preventing assembly and secretion of VLDL. We conclude that, when overexpressed, mir-148a, mir128 and mir-27a/b, mir-122 and mir-34 are related to decrease in LDLR, facilitating occurrence of atherosclerosis. While mir-30 has been linked to decreased atherosclerosis. Detection of miRNAs profile could be used in the future as a biomarker for disturbs linked to c-LDL uptake and in future anti-miRNAs therapies may be used in the treatment of atherosclerosis.